PopMuse: Biotechnology http://popmu.se Musings of stuff en-us Copyright 2007-2019 http://creativecommons.org/licenses/by-nc-sa/3.0/ Potato virus Y is the most serious threat to potato—some strains more than others https://phys.org/news/2019-11-potato-virus-threat-potatosome-strains.html https://phys.org/news/2019-11-potato-virus-threat-potatosome-strains.html Mon, 18 Nov 2019 21:51:02 UTC Biotechnology News - Biology News Potato virus Y (PVY) is the most serious problem facing the potato industry in the United States and is the main cause for rejection of seed potato lots. The virus affects potatoes in two ways: It reduces the yield of potato tubers by 70-80% and also negatively affects the quality of the remaining tubers due to necrotic reactions. http://creativecommons.org/licenses/by-nc-sa/3.0/ Tracking inheritance of human mitochondrial DNA https://phys.org/news/2019-11-tracking-inheritance-human-mitochondrial-dna.html https://phys.org/news/2019-11-tracking-inheritance-human-mitochondrial-dna.html Mon, 18 Nov 2019 20:00:12 UTC Biotechnology News - Biology News New insight into how genetic information stored in human mitochondria is passed from one generation to the next could have important implications for genetic counseling of women planning pregnancies, according to a study by researchers at Penn State and the University of California, Berkeley. The findings are especially relevant to women carrying disease-causing mutations within their mitochondrial DNA and those suffering from mitochondrial diseases. http://creativecommons.org/licenses/by-nc-sa/3.0/ Researchers clear the path for 'designer' plants https://phys.org/news/2019-11-path.html https://phys.org/news/2019-11-path.html Mon, 18 Nov 2019 18:46:55 UTC Biotechnology News - Biology News A team of researchers at the University of Georgia has found a way to identify gene regulatory elements that could help produce "designer" plants and lead to improvements in food crops at a critical time. They published their findings in two separate papers in Nature Plants. http://creativecommons.org/licenses/by-nc-sa/3.0/ Customer Success: Law Firm Business Development http://feedproxy.google.com/~r/BiotechBlog/~3/sS1IzYKsuqA/ http://feedproxy.google.com/~r/BiotechBlog/~3/sS1IzYKsuqA/ Mon, 18 Nov 2019 17:34:02 UTC DrugPatentWatch at Biotechblog DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks… The post Customer Success: Law Firm Business Development appear... The post Customer Success: Law Firm Business Development appeared first on Biotechblog. http://creativecommons.org/licenses/by-nc-sa/3.0/ Customer Success: Law Firm Business Development http://feedproxy.google.com/~r/BiotechBlog/~3/sS1IzYKsuqA/ http://feedproxy.google.com/~r/BiotechBlog/~3/sS1IzYKsuqA/ Mon, 18 Nov 2019 17:34:02 UTC DrugPatentWatch at Biotechblog DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks… The post Customer Success: Law Firm Business Development appear... The post Customer Success: Law Firm Business Development appeared first on Biotechblog. http://creativecommons.org/licenses/by-nc-sa/3.0/ AquaBounty plans to expand operations to other states, internationally https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/3EAF8CFB-F6D1-4606-80F6-62A9DA4EC46B https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/3EAF8CFB-F6D1-4606-80F6-62A9DA4EC46B Mon, 18 Nov 2019 16:25:57 UTC BIO SmartBrief AquaBounty, the developer of biotech AquAdvantage salmon, is currently negotiating with officials from various states outside�-More-� http://creativecommons.org/licenses/by-nc-sa/3.0/ Roche to acquire Promedior in $1.4B deal https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/F9E23E7A-8B05-46AA-91A9-BE27935401EC https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/F9E23E7A-8B05-46AA-91A9-BE27935401EC Mon, 18 Nov 2019 16:25:57 UTC BIO SmartBrief Roche has announced its intention to buy Promedior, a developer of anti-fibrotic medications, for $390 million upfront and an�-More-� http://creativecommons.org/licenses/by-nc-sa/3.0/ Takeda unveils details on 12 new molecular entities worth billions https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/88005EEB-68E6-47C5-AE94-8D9FB6C44121 https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/88005EEB-68E6-47C5-AE94-8D9FB6C44121 Mon, 18 Nov 2019 16:25:57 UTC BIO SmartBrief In a recent update, Takeda touted its plans for a dozen new molecular entities that could potentially generate 14 approvals a�-More-� http://creativecommons.org/licenses/by-nc-sa/3.0/ EC approves AstraZeneca's type 2 diabetes drug Qtrilmet https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/4009E1C5-4BD8-4B74-9A71-BE98776D2805 https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/4009E1C5-4BD8-4B74-9A71-BE98776D2805 Mon, 18 Nov 2019 16:25:57 UTC BIO SmartBrief AstraZeneca's Qtrilmet, or metformin hydrochloride, saxagliptin and dapagliflozin, was approved by the European Commission to�-More-� http://creativecommons.org/licenses/by-nc-sa/3.0/ Trump plans to let states buy meds from other countries https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/9BA11EAA-985C-4C56-8E77-9B30A7BBD974 https://www.smartbrief.com/branded/D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E/9BA11EAA-985C-4C56-8E77-9B30A7BBD974 Mon, 18 Nov 2019 16:25:57 UTC BIO SmartBrief President Donald Trump said he's planning to allow states to purchase prescription drugs from other countries as part of effo�-More-� http://creativecommons.org/licenses/by-nc-sa/3.0/